Sanguisorba officinalis L Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling (vol 10, 591400, 2020)
机构：[1]The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.[2]Integrative Research Laboratory of Breast Cancer, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China.广东省中医院[3]Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.广东省中医院
第一作者机构：[1]The Research Center for Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
推荐引用方式(GB/T 7714)：
Wang Neng,Muhetaer Gulizeba,Zhang Xiaotong,et al.Sanguisorba officinalis L Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling (vol 10, 591400, 2020)[J].FRONTIERS IN PHARMACOLOGY.2022,12:doi:10.3389/fphar.2021.810621.
APA：
Wang Neng,Muhetaer Gulizeba,Zhang Xiaotong,Yang Bowen,Wang Caiwei...&Wang Zhiyu.(2022).Sanguisorba officinalis L Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling (vol 10, 591400, 2020).FRONTIERS IN PHARMACOLOGY,12,
MLA：
Wang Neng,et al."Sanguisorba officinalis L Suppresses Triple-Negative Breast Cancer Metastasis by Inhibiting Late-Phase Autophagy via Hif-1α/Caveolin-1 Signaling (vol 10, 591400, 2020)".FRONTIERS IN PHARMACOLOGY 12.(2022)
医学